{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:11:57Z","timestamp":1767913917850,"version":"3.49.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.molmed.2010.01.006","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T10:55:21Z","timestamp":1269341721000},"page":"171-183","source":"Crossref","is-referenced-by-count":19,"title":["Proteomic approaches in the search for biomarkers of liver fibrosis"],"prefix":"10.1016","volume":"16","author":[{"given":"Matthew L.","family":"Cowan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony M.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.molmed.2010.01.006_bib1","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis \u2013 from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2010.01.006_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib4","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1572-0241.2004.30110.x","article-title":"Evaluation of liver fibrosis: a concise review","volume":"99","author":"Afdhal","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.molmed.2010.01.006_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2010.01.006_bib6","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/hep.20974","article-title":"Reversal of hepatic fibrosis \u2013 fact or fantasy?","volume":"43","author":"Friedman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-6143.2005.01143.x","article-title":"Antifibrotic agents for liver disease","volume":"6","author":"Albanis","year":"2006","journal-title":"Am. J. Transplant"},{"key":"10.1016\/j.molmed.2010.01.006_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2010.01.006_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10620-006-9493-6","article-title":"Liver biopsy: is the pain for real or is it only the fear of it?","volume":"52","author":"Akay","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.molmed.2010.01.006_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000071293","article-title":"Bleeding complications after percutaneous liver biopsy. An analysis of risk factors","volume":"67","author":"Terjung","year":"2003","journal-title":"Digestion"},{"key":"10.1016\/j.molmed.2010.01.006_bib11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nature06525","article-title":"The biological impact of mass-spectrometry-based proteomics","volume":"450","author":"Cravatt","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2010.01.006_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","article-title":"Use of proteomic patterns in serum to identify ovarian cancer","volume":"359","author":"Petricoin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2010.01.006_bib13","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(04)16046-7","article-title":"A novel and accurate diagnostic test for human African trypanosomiasis","volume":"363","author":"Papadopoulos","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2010.01.006_bib14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(06)69342-2","article-title":"Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum","volume":"368","author":"Agranoff","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2010.01.006_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/425905a","article-title":"Clinical proteomics: written in blood","volume":"425","author":"Liotta","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2010.01.006_bib16","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.molmed.2010.01.006_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1478-3231.1999.tb00033.x","article-title":"Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection","volume":"19","author":"Westin","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.molmed.2010.01.006_bib20","first-page":"869","article-title":"Assessment of liver histology in patients with hepatitis C and normal transaminase levels","volume":"8","author":"Stanley","year":"1996","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2893.1997.00141.x","article-title":"Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups","volume":"4","author":"Poynard","year":"1997","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.molmed.2010.01.006_bib22","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3748\/wjg.15.2433","article-title":"Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey","volume":"15","author":"Gressner","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.molmed.2010.01.006_bib23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2010.01.006_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2005.10.019","article-title":"Performance of serum marker panels for liver fibrosis in chronic hepatitis C","volume":"44","author":"Parkes","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib26","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/jhep.2002.36128","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model","volume":"36","author":"Forns","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib27","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2010.01.006_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2893.1998.00108.x","article-title":"Prediction of cirrhosis in patients with chronic hepatitis C infection by artificial neural network analysis of virus and clinical factors","volume":"5","author":"Haydon","year":"1998","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.molmed.2010.01.006_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10916-006-9023-2","article-title":"Support vector machine-based feature selection for classification of liver fibrosis grade in chronic hepatitis C","volume":"30","author":"Jiang","year":"2006","journal-title":"J. Med. Syst."},{"key":"10.1016\/j.molmed.2010.01.006_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hep.22735","article-title":"Back to the future with noninvasive biomarkers of liver fibrosis","volume":"49","author":"Guha","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib31","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jhep.2006.01.007","article-title":"Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C","volume":"44","author":"Sebastiani","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib32","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/gut.2003.030965","article-title":"Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C","volume":"54","author":"Lim","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2010.01.006_bib34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1148\/radiol.2402050606","article-title":"MR elastography of the liver: preliminary results","volume":"240","author":"Rouviere","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.molmed.2010.01.006_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.21747","article-title":"Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C","volume":"46","author":"Lewin","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib36","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/jhep.2003.50149","article-title":"The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C","volume":"37","author":"Lim","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hep.21318","article-title":"HepatoProteomics: applying proteomic technologies to the study of liver function and disease","volume":"44","author":"Diamond","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib38","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2893.2009.01083.x","article-title":"The HCV serum proteome: a search for fibrosis protein markers","volume":"16","author":"Cheung","year":"2009","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.molmed.2010.01.006_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1479-5876-5-33","article-title":"Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection","volume":"5","author":"White","year":"2007","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molmed.2010.01.006_bib40","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1373\/clinchem.2007.089144","article-title":"Novel serum biomarker candidates for liver fibrosis in hepatitis C patients","volume":"53","author":"Gangadharan","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2010.01.006_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1471-2407-9-271","article-title":"A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease","volume":"9","author":"Gray","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molmed.2010.01.006_bib42","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/pmic.200300394","article-title":"Serum biomarkers of hepatitis B virus infected liver inflammation: a proteomic study","volume":"3","author":"He","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.molmed.2010.01.006_bib43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/gut.2007.140087","article-title":"Serum proteomic profiling of obese patients: correlation with pathology and evolution after bariatric surgery","volume":"58","author":"Trak-Smayra","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2010.01.006_bib44","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1478-3231.2005.01117.x","article-title":"Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis","volume":"25","author":"Younossi","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.molmed.2010.01.006_bib45","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.3748\/wjg.v10.i16.2327","article-title":"New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology","volume":"10","author":"Zhu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.molmed.2010.01.006_bib46","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00432-007-0224-y","article-title":"Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification","volume":"133","author":"Cui","year":"2007","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.molmed.2010.01.006_bib47","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/hep.20577","article-title":"SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma","volume":"41","author":"Schwegler","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib48","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.3748\/wjg.v12.i47.7604","article-title":"New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples","volume":"12","author":"Gobel","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.molmed.2010.01.006_bib49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/bfgp\/3.4.322","article-title":"The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales","volume":"3","author":"Hu","year":"2005","journal-title":"Brief Funct. Genomic Proteomic"},{"key":"10.1016\/j.molmed.2010.01.006_bib50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1373\/clinchem.2004.041764","article-title":"Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study","volume":"51","author":"Poon","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2010.01.006_bib51","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1365-2036.2007.03427.x","article-title":"Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C","volume":"26","author":"Morra","year":"2007","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2010.01.006_bib52","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1128\/JVI.79.12.7558-7569.2005","article-title":"Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients","volume":"79","author":"Jacobs","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2010.01.006_bib53","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/jb\/mvj104","article-title":"Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein","volume":"139","author":"Sato","year":"2006","journal-title":"J. Biochem."},{"key":"10.1016\/j.molmed.2010.01.006_bib54","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/jhep.2000.9322","article-title":"Proteome analysis of rat hepatic stellate cells","volume":"32","author":"Kristensen","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib55","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/MEG.0b013e3282f4de92","article-title":"Proteomics in liver fibrosis is more than meets the eye","volume":"20","author":"Cheung","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib56","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/pmic.200400852","article-title":"A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers","volume":"4","author":"Low","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.molmed.2010.01.006_bib57","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/pmic.200400839","article-title":"Molecular classification of liver cirrhosis in a rat model by proteomics and bioinformatics","volume":"4","author":"Xu","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.molmed.2010.01.006_bib58","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/hep.21751","article-title":"Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction","volume":"46","author":"Diamond","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pmic.200800417","article-title":"Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison","volume":"9","author":"Cairns","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.molmed.2010.01.006_bib60","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep.22764","article-title":"Detection of novel biomarkers of liver cirrhosis by proteomic analysis","volume":"49","author":"Molleken","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib61","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1373\/clinchem.2008.114686","article-title":"Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory?","volume":"54","author":"Carr","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.molmed.2010.01.006_bib62","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/prca.200600771","article-title":"Clinical proteomics: a need to define the field and to begin to set adequate standards","volume":"1","author":"Mischak","year":"2007","journal-title":"Proteomics Clinical Applications"},{"key":"10.1016\/j.molmed.2010.01.006_bib63","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nrc1550","article-title":"Bias as a threat to the validity of cancer molecular-marker research","volume":"5","author":"Ransohoff","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2010.01.006_bib64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrc1322","article-title":"Rules of evidence for cancer molecular-marker discovery and validation","volume":"4","author":"Ransohoff","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2010.01.006_bib65","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1373\/clinchem.2005.051417","article-title":"Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption\/ionization mass spectrometry","volume":"51","author":"Banks","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2010.01.006_bib66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2105-4-24","article-title":"A data review and re-assessment of ovarian cancer serum proteomic profiling","volume":"4","author":"Sorace","year":"2003","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.molmed.2010.01.006_bib67","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/bioinformatics\/btg484","article-title":"Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments","volume":"20","author":"Baggerly","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.molmed.2010.01.006_bib68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1373\/clinchem.2004.038950","article-title":"Evaluation of serum protein profiling by surface-enhanced laser desorption\/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility","volume":"51","author":"Semmes","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2010.01.006_bib69","first-page":"99","article-title":"Clinical proteomics: present and future prospects","volume":"27","author":"Verrills","year":"2006","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.molmed.2010.01.006_bib70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/pmic.200400900","article-title":"Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples","volume":"5","author":"Bjorhall","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.molmed.2010.01.006_bib71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbpa.2006.01.008","article-title":"The amplified peptidome: the new treasure chest of candidate biomarkers","volume":"10","author":"Geho","year":"2006","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.molmed.2010.01.006_bib72","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1074\/mcp.M700354-MCP200","article-title":"Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution","volume":"6","author":"Keshishian","year":"2007","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.molmed.2010.01.006_bib73","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1373\/49.8.1272","article-title":"Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?","volume":"49","author":"Diamandis","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2010.01.006_bib74","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8278(03)00191-0","article-title":"Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease","volume":"39","author":"Colloredo","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib76","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gut.2005.084475","article-title":"An appraisal of the histopathological assessment of liver fibrosis","volume":"55","author":"Standish","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2010.01.006_bib77","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/jhep.2003.50319","article-title":"Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin","volume":"38","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib78","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2006.12.002","article-title":"Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?","volume":"46","author":"Castera","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib79","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Castera","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2010.01.006_bib80","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1007\/BF02087661","article-title":"Alpha-2-macroglobulin and hepatic fibrosis. Diagnostic interest","volume":"39","author":"Naveau","year":"1994","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.molmed.2010.01.006_bib81","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1572-0241.2004.04055.x","article-title":"Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid","volume":"99","author":"Leroy","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.molmed.2010.01.006_bib82","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.20772","article-title":"Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort","volume":"42","author":"Lok","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib83","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.21335","article-title":"Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection","volume":"44","author":"Fontana","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib84","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib85","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib86","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21520","article-title":"FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C","volume":"45","author":"Koda","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib87","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gut.2007.146019","article-title":"Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease","volume":"57","author":"Harrison","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2010.01.006_bib88","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/bbrc.1996.0360","article-title":"New alterations of serum glycoproteins in alcoholic and cirrhotic patients revealed by high resolution two-dimensional gel electrophoresis","volume":"220","author":"Gravel","year":"1996","journal-title":"Biochem. Biophys Res. Commun."},{"key":"10.1016\/j.molmed.2010.01.006_bib89","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.humpath.2006.07.007","article-title":"Direct and indirect evidence for the reversibility of cirrhosis","volume":"37","author":"Serpaggi","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.molmed.2010.01.006_bib90","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4321\/S1130-01082005001200002","article-title":"Long-term evolution of liver histopathology in patients with chronic hepatitis C and sustained response","volume":"97","author":"Moreno","year":"2005","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.molmed.2010.01.006_bib91","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","article-title":"Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct","volume":"344","author":"Hammel","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 3","key":"10.1016\/j.molmed.2010.01.006_bib92","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1111\/j.1440-1746.2006.04584.x","article-title":"Hepatic stellate cells and the reversal of fibrosis","volume":"21","author":"Kisseleva","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.molmed.2010.01.006_bib93","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.510230538","article-title":"Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis","volume":"23","author":"Baroni","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib94","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hep.21561","article-title":"Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis","volume":"45","author":"Pockros","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib95","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2010.01.006_bib96","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1073\/pnas.94.20.10663","article-title":"Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses","volume":"94","author":"Shi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2010.01.006_bib97","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hep.1840120209","article-title":"Collagen type I and III occur together in hybrid fibrils in the space of Disse of normal rat liver","volume":"12","author":"Geerts","year":"1990","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"10.1016\/j.molmed.2010.01.006_bib98","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1111\/j.1440-1746.2006.04586.x","article-title":"Matrix metalloproteinases, the pros and cons, in liver fibrosis","volume":"21","author":"Han","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib99","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02899560","article-title":"Temporal and spatial patterns of transin\/stromelysin RNA expression following toxic injury in rat liver","volume":"60","author":"Herbst","year":"1991","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"issue":"Suppl 2","key":"10.1016\/j.molmed.2010.01.006_bib100","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2105-6-S2-S5","article-title":"Quality control and quality assessment of data from surface-enhanced laser desorption\/ionization (SELDI) time of flight (TOF) mass spectrometry (MS)","volume":"6","author":"Hong","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.molmed.2010.01.006_bib101","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.21383","article-title":"Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C","volume":"44","author":"Honda","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.01.006_bib102","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jhep.2008.07.039","article-title":"Exceeding the limits of liver histology markers","volume":"50","author":"Mehta","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2010.01.006_bib103","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2007.01.003","article-title":"Hepatology may have problems with putative surrogate outcome measures","volume":"46","author":"Gluud","year":"2007","journal-title":"J. Hepatol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491410000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491410000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T09:24:29Z","timestamp":1544606669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491410000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1471491410000195"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2010.01.006","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}